Out-of-Pocket Costs

File Downloads / Links

The Inflation Reduction Act of 2022: One Year Anniversary Highlights from ASPE Drug Pricing Reports

The report from the U.S. Department of Health and Human Services’ ASPE features key findings from the first year of implementing IRA provisions regarding Medicare drug coverage. The report also includes information on the IRA implementation timeline, and highlights from research reports on the impact of the IRA on the following: caps on out-of-pocket costs for insulin; access to vaccines without cost-sharing; provisions regarding drugs covered under Medicare Part B; and Medicare Part D benefit redesign and out-of-pocket cap.

Short URL: http://www.advancingstates.org/node/74810

File Downloads / Links

It Pays to Shop: Variation in Out-of-Pocket Costs for Medicare Part D Enrollees in 2016

The Kaiser Family Foundation released an issue brief that analyzes the cost of Medicare Part D drug plans, specifically out-of-pocket costs for Medicare beneficiaries. A major finding from the brief showed that Medicare Part D enrollees may pay thousands of dollars of out-of-pocket costs if they require a specialty drug, even after exceeding the catastrophic coverage threshold. This study's findings emphasize how important it is for beneficiaries to diligently shop for new plans each year.

Short URL: http://www.advancingstates.org/node/67140

Subscribe to RSS - Out-of-Pocket Costs